Genito Urinary System and Sex Hormones

Interstitial Cystitis market comprises robust pipeline therapies in late and mid-stage development, which are expected to be launched shortly, such as KRP-116D (Kyorin Pharmaceutical), Certolizumab pegol/ Cimzia (UCB Pharma), LP-08 (Lipella Pharmaceuticals), GRT6010 (Grünenthal), ASP6294 (Astellas Pharma), and SI-722 (Seikagaku Corporation). Interstitial Cystitis (IC), also known as Bladder Pain Syndrome (BPS) is a chronic syndrome that results in recurring fits of pain and pressure in the bladder and pelvic. Due to the presence of multiple potential etiologies and varying symptoms from patient-to-patient, the disease is regarded as complex and challenging to und...